What will be the outcome of the Senate vote on the Biosecure Act by February 28, 2025?
Passed with amendments • 25%
Passed without amendments • 25%
Rejected • 25%
Postponed • 25%
Official Senate voting record
Congress Weighs Biosecure Act to Restrict Blacklisted Chinese Biotech Firms Over DNA Collection
Dec 5, 2024, 03:39 PM
The U.S. Congress is considering the Biosecure Act, a legislative measure aimed at restricting blacklisted Chinese biotechnology firms linked to the Chinese military from operating in the United States. These companies are allegedly collecting DNA data from American citizens and using it for military experiments, including the development of bio-weapons and complex viruses. The bill has passed the House of Representatives and now awaits Senate approval. Supporters of the bill argue that it is essential for safeguarding national security, economic independence, and preventing potential threats posed by Chinese military-linked entities. Lawmakers are reportedly exploring a potential compromise to advance the legislation.
View original story
Not voted on • 25%
Passes with majority • 25%
Passes with tie-breaking vote • 25%
Fails • 25%
Pass • 25%
Not Considered • 25%
Fail • 25%
Amended and Passed • 25%
Fail • 25%
Pass with more than 60 votes • 25%
Pass with 51-60 votes • 25%
Not voted by deadline • 25%
Passes with 80 or more votes • 25%
Fails to pass • 25%
Passes with 70-79 votes • 25%
Passes with 60-69 votes • 25%
Rejected • 25%
No vote by December 31, 2025 • 25%
Passed with amendments • 25%
Passed without amendments • 25%
Fail • 25%
Other • 25%
Pass with transgender care ban • 25%
Pass without transgender care ban • 25%
Passed with amendments • 25%
Postponed • 25%
Failed • 25%
Passed without amendments • 25%
Fail • 25%
Pass • 25%
Withdrawn • 25%
Postponed • 25%
Postponed • 34%
Fail • 33%
Pass • 33%
Fail • 25%
Pass with amendments • 25%
Other • 25%
Pass with current provisions • 25%
Passed with Democratic majority only • 25%
Passed with bipartisan support • 25%
Passed with Republican majority only • 25%
Failed to pass • 25%
Economic impact • 25%
Other • 25%
Civil liberties concerns • 25%
Diplomatic relations with China • 25%